Skip to main content

Michael J. Naslund, MD

John D. Young, Jr. Professor of Urology

Academic Title:


Primary Appointment:


Administrative Title:

Division Head, Surgical Urology

Additional Title:

Professor and Chief, Division of Urology University of Maryland School of Medicine


29 South Greene Street Suite 500 Baltimore, MD. 21030

Phone (Primary):

(410) 328-0800


(410) 328-0595

Education and Training




            1973-1977:                              B.S. (1977) DavidsonCollege

                                                            Davidson, North Carolina


            1977-1981:                              M.D. (1981) The Johns Hopkins University

                                                            School of Medicine, Baltimore, Maryland


            1990-1992:                              M.B.A. (1992) The Wharton School of  Finance,

                                                            Philadelphia, Pennsylvania





            1981-1983                               General Surgery Residency

                                                            The JohnsHopkinsHospital

                                                            Baltimore, Maryland


            1983-1987                               Urology Residency

                                                            The JohnsHopkinsHospital

                                                            Baltimore, Maryland




I have clinical interests in benign prostatic enlargement (BPH) and prostate cancer.  I treat men who have urinary symptoms from an enlarged prostate with medication and , if needed, surgical procedures.  A multi-disciniplinary approach is used to mange men who have frequent urination at night. Minimally invasive options such as laser surgery are available.  Prostate cancer can be treated with robotic surgery, proton beam radiation or brachytherapy (seed radiation).  The treatment option offered is tailored to the needs of each individual patient.  In men with low grade, slow growing prostate cancer active surveillance is offered as an option to spare men the side effect risk of prostate cancer treatment.   Prostate mri scanning and mri based fusion prostate biopsies are available to improve the accuracy of prostate biopsies and to avoid unnecessary biopsies.  

Research/Clinical Keywords

benign prostatic hyperplasia, prostate cancer

Highlighted Publications





Sausville, J. and Naslund, M.: Benign Prostatic Hyperplasia and Prostate Cancer: An Overview For Primary Care Physicians.  Int. J. Of Clinical Practice. 64: 1740, 2010.

Franklin, R., Zou, J., Zheng, Y., Naslund, M., and Costello, L.:Zinc Ionophore (Clioquinol) Inhibition of Human ZIP1-Deficient Prostate Tumor Growth in the Mouse Xenograft Model: A Zinc Approach for the Efficacious Treatment of Prostate Cancer.  Intl. Journal of Cancer and Clinical Research 2016, 3:037

Holt, CL,Saunders, DR, Wang, MQ, Slade, JL, Muwwakkil, B, Williams, R, Atkinson, NL, Whitehead, TL and Naslund, MJ. Informed Decision-Making and Satisfaction with a Church-Based Men’s Health Workshop Series for African-American Men:Men-Only vs. Mixed Gender Format. J. Cancer Educ. 2015: 30(3), 530-534.

Helfand, BT, , Lee JY, McVary KT; Naslund MJ, Sharp, V. Williams OD,   Harris,F. Associations between improvements in lower urinary tract symptoms and sleep disturbance over time in the CAMUS trial.   Journal of  Urology 2012;188(6):2288-93.

.      Barry MJ, Meleth S, Lee JY, Kreder KJ, Avins AL, Nickel JC, Roehrborn CG,     Crawford ED, Foster HE Jr, Kaplan SA, McCullough A, Andriole GL, Naslund            MJ, Williams OD, Kusek JW, Meyers CM, Betz JM, Cantor A, McVary KT; Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Study Group. JAMA. 2011 Sep 28;306(12):1344-51.


Awards and Affiliations

Past president of American Association of Clinical Urologists.

Past president of Mid-Atlantic Section, American Urological Association.

Member of American Urological Association and American Association of Clinical Urologists.